BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22073570)

  • 1. [Classification and the staging of chronic obstructive pulmonary disease and assessment of determinant factors of prognosis].
    Fukuoka A; Kimura H
    Nihon Rinsho; 2011 Oct; 69(10):1763-9. PubMed ID: 22073570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.
    Huijsmans RJ; de Haan A; ten Hacken NN; Straver RV; van't Hul AJ
    Respir Med; 2008 Jan; 102(1):162-71. PubMed ID: 17881207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.
    Celli BR; Cote CG; Marin JM; Casanova C; Montes de Oca M; Mendez RA; Pinto Plata V; Cabral HJ
    N Engl J Med; 2004 Mar; 350(10):1005-12. PubMed ID: 14999112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stage and prognosis of COPD].
    Akashiba T
    Nihon Rinsho; 2003 Dec; 61(12):2089-93. PubMed ID: 14674315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE.
    de Torres JP; Casanova C; Marín JM; Pinto-Plata V; Divo M; Zulueta JJ; Berto J; Zagaceta J; Sanchez-Salcedo P; Cabrera C; Carrizo S; Cote C; Celli BR
    Thorax; 2014 Sep; 69(9):799-804. PubMed ID: 24969641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
    Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
    Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a multidimensional staging system for chronic obstructive pulmonary disease.
    Celli BR; Calverley PM; Rennard SI; Wouters EF; Agusti A; Anthonisen N; Macnee W; Jones P; Pride N; Rodriguez-Roisin R; Rossi A; Wanner A
    Respir Med; 2005 Dec; 99(12):1546-54. PubMed ID: 16291077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive validity of BODE index for anxious and depressive symptoms in patients with chronic obstructive pulmonary disease.
    An L; Lin YX; Yang T; Zhang H; Jiao X; Zhang S; Chang XH; Wang ZM; Wang C
    Chin Med J (Engl); 2010 Jul; 123(14):1845-51. PubMed ID: 20819566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From COPD to chronic respiratory failure].
    Chabot F; Gomez E; Guillaumot A; Chaouat A
    Rev Prat; 2011 Jun; 61(6):781-6. PubMed ID: 21826921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
    Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
    Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease.
    Grabicki M; Parysek H; Batura-Gabryel H; Brodnicka I
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():297-301. PubMed ID: 19218653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COPD: criteria for diagnosis and classification of disease severity].
    Yamaguchi K
    Nihon Rinsho; 2007 Apr; 65(4):657-63. PubMed ID: 17419384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between quality of life and BODE index of stable ex-smokers with chronic obstructive pulmonary disease].
    Koblízek V; Salajka F; Cermáková E; Tomsová M; Pohnetalová D; Papousek P; Bartos V; Dobesová T; Paráková Z; Ruta J; Sedlák V
    Vnitr Lek; 2009 Oct; 55(10):940-7. PubMed ID: 19947238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global assessment of the COPD patient: time to look beyond FEV1?
    Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
    Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic obstructive pulmonary disease: definition and classification of severity].
    Romagnoli M; Fabbri LM
    Ann Ist Super Sanita; 2003; 39(4):461-6. PubMed ID: 15098568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in a recent study of 625 patients with chronic obstructive pulmonary disease compared with results of 3 older studies.
    Singer RB
    J Insur Med; 2005; 37(3):179-84. PubMed ID: 16259207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.